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Abstract
Background: West Nile Virus (WNV) infection has been reported worldwide, including in Africa but its existence in Zam-
bia is unknown. Symptoms for the virus include headache, myalgia, arthralgia and rash.
Objectives: This study aimed to determine the seroprevalence of  WNV and its correlates. 
Methods: A cross sectional study was conducted in North-Western and Western provinces of  Zambia.  Samples were 
subjected to IgG and IgM antibodies testing against WNV.  Logistic regression analyses were conducted to determine mag-
nitudes of  association. 
Results: A total of  3,625 of  persons participated in the survey out of  which 10.3% had WNV infection.  Farmers were 
20% (AOR=0.80; 95% CI [0.64, 0.99]) less likely to have infection compared to students. Meanwhile participants who lived 
in grass roofed houses were 2.97 (AOR=2.97; 95% CI [1.81, 4.88]) times more likely to be infected than those who lived in 
asbestos roofed houses. IRS was associated with reduced risk of  infection (AOR=0.81; 95% CI [0.69, 0.94]).  Travelling to 
Angola was associated with the infection [AOR=1.40; 95% CI [1.09, 1.81].
Conclusion: Spraying houses with insecticide residual spray would minimize mosquito-man contact.  Furthermore, surveil-
lance at the border with Angola should be enhanced in order to reduce importation of  the virus into the country.
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Introduction
West Nile Virus (WNV) is a member of  the flaviviridae 
family and genus Flavivirus, transmitted by Culex mos-
quito species1,2. Birds are its natural host and they play 
a major role in the geographic dispersion of  the virus. 
Humans become infected by the virus through mosqui-
to bites3-5. It is estimated that one out of  150 human 
infections could result in severe neurologic symptoms 
with a death rate of  10% among severe cases6-8.  Most 
of  the infections are usually asymptomatic but those 
who show symptoms come down with headaches, my-
algia, arthralgia and rash. Currently no treatment exists 
for arboviral diseases and there are no licensed vaccines 
for humans, therefore preventive measures against in-
fection with WNV are encouraged9-11.
 
The virus was first discovered in Uganda in 193712. 
In America, the disease was not considered as an im-
portant health problem until 1999 when 62 deaths 
occurred in North America13,14. The disease has since 
been reported globally15.  Several WNV seroprevalence 
studies had been conducted worldwide including; Ita-
ly, the United States of  America and Romania. In Italy 
WNV seroprevalence ranged from 3 per 1,000 blood 
donors to 33 per 1,000 blood donors16. Studies in USA 
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indicated that in-country variations existed with higher 
WNV seroprevalence rates in the Western and central 
areas (19.7% and 13.8% respectively) and lower rates of  
4.2% in the Eastern parts17.
WNV human infections had been reported in many 
African countries. Studies conducted in Egypt in the 
1950s and 1970s showed WNV antibodies in serum 
samples of  more than 60% of  the study population and 
74% in Upper parts of  Egypt and 28% around Cairo18. 
In Tunisia, in the 1960s and some areas in North Africa 
showed a seroprevalence of  5%, while Senegal reported 
higher rates of  up to 98%2. Prevalence rates of  3-65% 
were reported in Kenya between 1966 and 19682 and 
9.2% in 201119. Studies in South Africa reported sero-
prevalence of  13–24% in 1961–1965  PubMed and up 
to 45% in Madagascar2.
 
Several risk factors for WNV infection emerged from 
the study in America such as climate and  transmission 
even after adjusting for other environmental factors20 
and the results were comparable to results obtained in 
other studies which confirmed an association between 
urban/sub-urban versus a more rural area21,22.  Howev-
er other studies reported significant association when 
there was less population density and rural. Tempera-
ture changes determining human activity and mosquito 
replication was also significantly associated with risk of  
infection. It was also concluded that these factors could 
differ yearly due to changes in bird populations with 
high bird population as being protective20.  It is possible 
that when there are more birds the virus could be con-
centrated in bird mosquito bird cycle whereas if  there 
are fewer birds the mosquito could resort to human 
meals. In Arizona staying at home and not attending 
school was found to be a risk factor to WNV infection, 
although it was argued that the possibility that those 
who stayed at home were the elderly who were already 
known to be at high risk of  infection with WNV11.   Se-
roprevalence studies conducted in Cameroon had indi-
cated that iron roofed houses were protective for the 
infection compared to grass thatched houses23.
 
Studies had also confirmed that age had a bearing on 
the severity of  the infection with the older age group, 
50 years and above, being most at risk20. However other 
studies reported that WNV affects all age groups; In 
Israel and other parts of  Africa infection was reported 
in children and healthy adults2,24.  In Kenya the sero-
prevalence tended to increase with age19.
 
Although WNV infection has been reported world-
wide, there has been no information on the extent of  
the problem in Zambia. Therefore, this study was con-
ducted to determine the seroprevalence of  WNV IgG 
and IgM antibodies and its correlates in Zambia during 
a Yellow fever risk assessment survey.
 
Methods
Study site, design and population
The study was conducted in North-Western and West-
ern provinces of  Zambia. The selection of  the two 
provinces was based on the classification as low poten-
tial risk areas for yellow fever transmission by World 
Health Organization (WHO) in 201025. North-West-
ern province which borders with Angola on the west-
ern side and Democratic Republic of  Congo (DRC) 
on the northern side has a population of  706,46226. It 
is the most sparsely populated province in the coun-
try and the provincial capital is Solwezi. The province 
comprised of  8 districts which were divided into 1178 
Standard Enumeration Aras (SEAs) and the main eco-
nomic activities were mining in one district and general 
pineapple growing. Western province with a population 
of  881,524, borders with Angola and has seven districts 
(Census 2010) divided into 1902 SEAs. The main eco-
nomic activities were crop farming, livestock produc-
tion and fishing.  A cross sectional study was carried out 
among individuals aged nine months or older. 
 
Sample size, inclusion/exclusion criteria and sam-
pling
The sample size calculation was based on the assump-
tion that the sero-prevalence was 7% based on the study 
conducted by Robinson27.  In estimating the sample size 
for persons aged 5 years or older, the following param-
eters were considered: a prevalence of  7%, desired pre-
cision or confidence interval (d) of  +3%, and a design 
effect (DE) of  2 and an 80% response rate.  Consider-
ing sex, we aimed to recruit 700 male and 700 female 
participants in each province. Assuming an average of  4 
persons aged 5 years or older in each household, a total 
of  12 households in each of  the 30 cluster was to be 
recruited in the survey.  The total number of  persons 
that would be recruited from each province was 1806, 
totaling 3612 from both provinces.
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The seroprevalence of  children was about half  that for 
older children, and in estimating the sample size for 
persons aged below 5 years, the following parameters 
were considered: a prevalence of  3.5%, desired preci-
sion or confidence interval (d) of  +3.4%, and a design 
effect (DE) of  2 and an 80% response rate. The com-
puted sample size was 282.  Therefore, in each province 
406 children would be recruited for the survey.
 
Included in the study were individuals aged 9 months 
or older who were found in a sampled household at the 
time of  the study and were resident in the study site for 
at least seven days. Individuals who had received YF 
vaccination in the last ten years to the survey were also 
included in the survey.  Excluded from the study were 
persons who were aged less than 9 months, or individ-
uals regardless of  age who resided in the study site for 
less than 7 days prior to the survey. Children under the 
age of  9 months were excluded based on the fact that 
at this age children could still carry maternal antibodies 
from exposed mothers which could pose the risk of  
false positive results. 
 
The sample was drawn using a two-stage cluster sam-
pling technique using probability proportional to size. 
A list of  the standard enumeration areas (SEAs) in each 
province constituted the sampling frame.  The line lists 
of  the SEAs were provided by the Government's Cen-
tral Statistics Office (CSO). The sampling was designed 
to achieve fairly good estimates at the provincial level 




Dependent variable:  A case with evidence of  WNV 
exposure was defined as any individual aged 9 months 
or older whose blood sample was confirmed to have 
WNV exposure. WNV exposure status was positive if  
IgG or IgM antibodies were determined in the serum 
sample by laboratory testing and negative if  the IgG or 
IgM antibodies were absent by laboratory testing.
Independent variables:  The independent variables 
included demographic data: age, sex, occupation, edu-
cation, roof  type and use of  mosquito preventive meas-
ures such as insecticide treated nets (ITNs) and indoor 
residual spray (IRS). 
Laboratory procedures
Three to 5 millilitres of  blood was collected by ve-
nepuncture into an EDTA vaccutainer tube and trans-
ported on cold chain to the local laboratories for serum 
separation and storage.  
Subsequently serum samples were transported on cold 
chain and thereafter subjected to primary testing (YFV 
specific IgG and IgM) at the University of  Teaching 
Hospital in Zambia virology unit and Institute Pasteur, 
Dakar. All presumptive YFV-specific IgG and IgM 
samples were subjected to IgG and IgM antibodies 
testing against other flaviviruses known to cause haem-
orrhagic fever-likedisease including WNV. The testing 
was carried out using IgG capture enzyme-linked im-
munosorbent assay (ELISA).
 
Data management and analysis
Data collected from the field was entered in an Epi-Info 
data entry screen that had consistency and range checks 
embedded in it. Further editing was conducted by run-
ning frequencies during the analysis stage. Epi data files 
were exported to SPSS for data analysis. The data was 
summarized to describe the occurrence of  WNV ex-
posed individuals in absolute numbers and percentage 
by place (residence, travel or work) and person (age, sex, 
occupation, education).  Further analysis was conduct-
ed to determine independent factors associated with 
WNV sero-positivity. Odds ratios were used to estimate 
the magnitude of  associations.
 
Ethical considerations
Ethical clearance was sought from the Tropical Diseas-
es Research Centre Research Ethics Committee, and 
ethical standards were adhered to throughout this study. 
Informed consent was sought from study participants. 
Guardians provided assent for the participation of  the 
persons under the consenting age. They were asked to 
read or have read to them, understand and sign/thumb-
print an informed consent form. Responsible adults in 
the household were identified to give proxy consent on 
behalf  of  minors. 
 
Results
Table 1 provides a description of  the respondents in 
the two provinces. A total of  3,625 persons participat-
ed in the survey.  About 1 in 5 of  the participants was 
in the age groups 5-14 years (23.9%) and 15-24 years 
(20.6%).  The sample comprised more female partici-
pants (53.3%).  Male participants tended to be more ed-
ucated than females (p<0.001) with 35.9% of  male and 
26.6% of  female participants having attained secondary 
level of  education or higher.  
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Table 1: Sample description for the two provinces 
 
Factors Total % Male % Female % 
Age (years) [x2 =10.41, p=0.065] 
<5 335 9.4 155 9.3 178 9.4 
5-14 853 23.9 424 25.4 429 22.6 
15-24 738 20.6 344 20.6 392 20.6 
25-34 593 16.6 245 14.7 348 18.3 
25-44 460 12.9 214 12.8 245 12.9 
45+ 596 16.7 286 17.1 310 16.3 
Sex 
Male 1669 46.7         
Female 1902 53.3         
Education [x2=41.72, p<0.001] 
None 758 21.5 312 19.0 444 23.6 
Primary 1680 47.6 741 45.1 937 49.8 
Secondary 996 28.2 529 32.2 466 24.8 
College / 
University 
95 2.7 61 3.7 34 1.8 
Occupation [x2=245.60, p<0.001] 
House 
wife/husband 
307 8.7 18 1.1 289 15.4 
Farming 1233 35.1 573 35.1 659  
  
No significant association was observed between West 
Nile virus infection and sex (p=0.868). Overall, 10.3% 
of  the participants had WNV infection.
Table 2 provides an analysis of  factors associated with 
West Nile Virus infection. Of  the factors considered, 
age, education, occupation, roof  type, sleeping under 
an ITN, house with IRS, visited DRC, visited Angola, 
occupation and roof  type were significantly associated 
with West Nile infection.  Compared with participants 
of  age 45 years or older, participants aged less than 5 
years were 62% (AOR=0.38; 95% CI [0.20, 0.73]) less 
likely to have infection, while, participants aged 35-44 
years were 41% (AOR=1.41; 95% CI [1.01-1.97]) more 
likely to have infection.  
Table 2: Factors associated with West Nile Virus infection in bivariate and multivariate 
analysis for two provinces 
  
Factor OR 95% CI AOR 95% CI 
Age (years) 
<5 0.31 (0.18-0.53) 0.38 (0.20-0.73) 
5-14 0.73 (0.56-0.94) 0.73 (0.50-1.08) 
15-24 1.06 (0.83-1.36) 1.07 (0.82-1.42) 
25-34 1.18 (0.91-1.53) 1.06 (0.77-1.48) 
35-44 1.49 (1.14-1.94) 1.41 (1.01-1.97) 
45+ 1   1 1 
Sex 
Male  1.02 (0.91-1.13) -   
Female  1       
Education  
None  0.86 (0.65-1.14) 0.83 (0.60-1.15) 
Primary  1.42 (1.12-1.80) 1.32 (1.01-1.72) 
Secondary  1.04 (0.80-1.35) 0.98 (0.74-1.30) 
College/University 1   1   
Slept under mosquito net 
Yes  1.13 (1.01-1.27) 1.13 (1.00-1.27) 
No  1   1   
House with IRS 
Yes  0.83 (0.72-0.96) 0.81 (0.69-0.95) 
No 1   1   
Travelled to Congo DR 
Yes  0.30 (0.11-0.79) 0.28 (0.10-0.74) 
No  1   1   
Travelled to Angola 
Yes  1.68 (1.32-2.12) 1.40 (1.09-1.81) 
No  1   1   
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Participants who had attained primary level of  educa-
tion were 32% (AOR=1.32; 95% CI [1.01, 1.72]) more 
likely to have infection compared to participants who 
had attained higher level of  education.  Farmers were 
20% (AOR=0.80; 95% CI [0.64, 0.99]) less likely to 
have infection compared to students. Meanwhile, par-
ticipants who lived in grass roofed houses were 2.97 
(AOR=2.97; 95% CI [1.81, 4.88]) times more likely to 
be infected than those who lived in asbestos roofed 
houses. Compared with participants who did not have 
their houses sprayed those who had IRS in their houses 
were 19% (AOR=0.81; 95% CI [0.69, 0.94]) less like-
ly to have infection.  Participants who had travelled to 
DRC were 72% (AOR=0.28; (%% CI [0.10, 0.74]) less 
likely to have infection compared with those who did 
not travel there.  Travelling to Angola was associated 
with the infection [AOR=1.40; 95% CI [1.09, 1.81]).
 
Discussion
This study presents the first documentation of  the se-
roprevalence of  WNV infection and its correlates in 
Zambia. The results of  this survey revealed a seroprev-
alence of  10.2%. The following factors were statistically 
significantly associated with the infection: age, educa-
tion, occupation, roof  type, living in a house with IRS, 
sleeping under a mosquito net and visiting Congo DR 
and Angola.
 
The seroprevalence results obtained in this study were 
consistent with results from surveys conducted in other 
parts of  the world including Africa although in some 
areas very high seroprevalence rates of  WNV infection 
were obtained. The seroprevalence in USA varied across 
the country with rates ranging from 4.2%-19.7%19. In 
Africa higher rates of  (60%-74%) in Egypt, (3%-65%) 
in Kenya and (13%-24%) in South Africa, were report-
ed as way back as the 1950s to 1970s2,17. It is also impor-
tant to note that most of  these studies were conducted 
on blood donors following an outbreak, which could 
explain the marked difference in the rates obtained in 
this study.
 
Disease prevalence is dependent upon a wide range of  
risk factors, climate and the environment affecting the 
activities of  the virus and the humans20-22,28.  This study 
has shown that being younger than 5 years old was pro-
tective to the WNV infection while literature indicates 
that all age groups are at risk for the disease20. This 
study however indicates that those aged between 35-44 
years of  age were more likely to acquire the infection 
compared to those who were 45 years older. Contrary 
to other literature which suggests that those above 50 
years of  age were more at risk for the disease compared 
to those below the age of  50 years20. 
 
Regarding vector management and control the study 
has shown that participants, who had a house with IRS, 
were less likely to be infected with the virus compared 
to those who did not have their houses sprayed. There-
fore the national malaria control program should sustain 
efforts to attain higher IRS coverage as this provides 
protection again arthropod-borne viruses, including the 
WNV, in addition to malaria, to the beneficiaries. CDC 
guidelines on WNV surveillance control and preven-
tion call for active surveillance of  the disease in humans 
and integrated vector management. The guidelines em-
phasize that since WNV outbreaks are non-predictable 
there is a need for active surveillance to monitor and 
detect increases in the disease rates and to have control 
measures readily available for outbreak response.
 
There is evidence of  arboviral outbreaks in Africa with 
recent reports of  dengue outbreaks in Angola, DRC 
and Tanzania, which are neighbors with Zambia. Travel 
between Zambia and these countries is inevitable, in-
creasing the risk of  viral importation. This study pro-
vides evidence that participants who had a history of  
travelling to Angola were at an increased risk of  being 
infected with WNV. Human movement has been impli-
cated in the spread and transmission of  vector borne 
diseases including WNV29.  It should therefore be em-
phasized that travelers take personal protective meas-
ures against mosquito bites as a preventive measure. 
 
Concerning education level of  the participants, this 
study demonstrates that compared to participants who 
had attained tertiary level of   education, those who had 
attained primary school level of  education were more 
likely to be infected with WNV. This finding contradicts 
studies in Arizona which indicated that those who did 
not attend school were more at risk of  the disease than 
those who attended school11.  This is not surprising as 
literacy is generally a symbol of  improved socioeco-
nomic status leading to increased chances of  access to 
medical care resulting in reduced chances of  exposure 
to the disease29.  
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This study has indicated that seropositivity was signif-
icantly associated with living in grass thatched houses 
compared to living in asbestos roofed houses. Contra-
ry to results in Cameroon where grass thatched houses 
were protective against vector borne diseases compared 
to the iron roofed houses23. Regarding occupation of  
the participants, being a farmer was protective to the in-
fection. This finding suggests that mosquito-man con-
tact may not be occurring when farmers are in the field.
 
The findings in this study could be limited by the fact 
that the results were based on primary IgG and IgM 
antibody test. Plaque Reduction Neutralization Test 
(PRNT) was not done. This could have inflated the se-
ropositivity for WNV since the cross reactivity of  ar-
boviruses was not taken into consideration, although 
another similar study which carried out the PRNT fol-
lowing the primary test showed that about 80% of  the 
primary results were confirmed1. The other limitation 
could be the fact that the association of  WNV and 
the veterinary and avian populations which exist in the 
provinces was not done.
 
Conclusion 
This study provides evidence that WNV infection is 
prevalent in North-Western and Western provinces of  
Zambia.  Further studies are needed to determine the 
disease burden in veterinary, mosquitoes, avian and hu-
mans. Spraying houses with insecticide residual spray 
would minimize mosquito-man contact.  Furthermore, 
surveillance at the border with Angola should be en-
hanced in order to reduce importation of  the virus into 
the country.
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